4:00 PM – 7:30 PM

Registration Open

Exhibit & Poster Set-Up

6:00 pm – 7:30 pm

Welcome Reception

Join us for the Welcome Reception at the Cheyenne Mountain Resort Grand Rivers Terrace and launch into the fabulous 2025 WAGO Annual Meeting! You’ll be basking in breathtaking mountain views and soaking up the beauty of the majestic Rocky Mountains!

6:30 AM – 8:00 AM

Breakfast

6:30 PM – 12:00 PM

Registration Open

8:00 AM – 8:10 AM

Welcome & Opening Remarks

8:10 AM -9:15 AM

General Session 1

9:15 AM – 9:30 AM

Break

9:30 AM – 11:05 AM

General Session 2

11:05 AM – 12:05 PM

Presidential Lecture

12:05 PM – 1:50 PM

Industry Supported Symposium

5:30 PM – 7:00 PM

Networking Event

6:30 AM – 8:00 AM

Breakfast

6:30 AM – 12:00 PM

Registration Open

7:00 AM – 8:00 AM

Trainee & Early-Career Faculty Session

7:00 AM – 8:00 AM

WAGO Business Meeting

8:15 AM – 9:20 AM

General Session 3

9:20 AM – 9:35 AM

Break

9:35 AM – 10:40 AM

General Session 4

10:40 AM – 11:40 AM

Tumor Board

11:55 AM – 1:25 PM

6:00 PM – 8:00 PM

President’s Reception

Join us at the President’s Reception for an evening of celebration at the Garden of The Gods Resort amidst the breathtaking views of the stunning red rock sandstone formations, set against the backdrop of Pikes Peak. This remarkable venue offers a serene and captivating atmosphere, untouched and tranquil, surrounded by awe-inspiring natural beauty.

6:30 AM – 8:00 AM

Breakfast

6:30 AM – 12:00 PM

Registration Open

6:30 AM – 8:00 AM

Poster Presentations & Exhibit Hall Open

7:00 AM – 8:30 AM

ASCO Update

8:30 AM – 9:35 AM

General Session 5

9:35 AM – 9:55 AM

Break

9:55 AM – 11:30 AM

General Session 6

11:25 AM – 11:30 AM

Closing Remarks & WAGO 2026 Annual Meeting Location Announcement

WAGO 2026 Annual Meeting

Wednesday, June 17 –  Saturday, 20, 2026

2024 WAGO Annual Meeting

Wednesday, June 12 – Saturday, June 15

Seattle, Washington

Fairmont Olympic Hotel Seattle

Click here for a pdf of the 2024 WAGO Annual Meeting Schedule of Events.

2024 Poster Presentations

Poster #1

Understanding the Role of at-risk cytology and co-testing categories in cervical cancer development: are current tactics in management sufficient?

Presenting Author: Caroline Doyle, BS

Poster #2

Clinical characteristics of patients with cervical cancer undergoing fertility-sparing surgery with cervical excision and lymph node evaluation

Presenting Author: Ashley Zhang, BS

Poster #3

Predicting final pathologic diagnosis by cervical excision margins and endocervical curettage

Presenting Author: Ryan Woodson, MD

Poster #4

Survival in HPV and non-HPV associated invasive cervical cancer: outcomes in a large, integrated healthcare system

Presenting Author: Gracie Williams, MD

Poster #5

The relationship between history of sexual assault and cervical cancer: A meta-analysis

Presenting Author: Kyra Hunsberger, BA

Poster #6

Characterization of Patients with Recurrent and Persistent Cervical Cancer after Chemoradiation Therapy: A Retrospective Chart Review

Presenting Author: Lauren Quinto, MD

Poster #7

Association of Time to Surgery and Rates of Endometrial Cancer in Patients with Endometrial Intraepithelial Neoplasia

Presenting Author: Justin Kim, MD

Poster #8

The Clinical Course of Atypical Polypoid Adenomyoma: A Rare Lesion of Ovulatory Dysfunction

Presenting Author: Susan Lang, MD

Poster #9

Surgical complications with and without removal of the uterus during proctectomy following pelvic radiation for colorectal malignancy

Presenting Author: Roshni Ray, MD

Poster #10

Rate of homologous recombination repair gene expression in endometrial cancer patients

Presenting Author: Alexandra Smick, MD

Poster #11

Long-term survival outcomes of robotic-assisted versus traditional laparoscopy for the treatment of stage I endometrial cancer: a National Cancer Database analysis

Presenting Author: Sarah Davidson, MD

Poster #12

Clinical outcomes in non-English-speaking women undergoing cervical cancer treatment

Presenting Author: Laura Potter, BA

Poster #13

Sociodemographic Factors Associated with Distress among a Diverse Gynecologic Oncology Patient Population

Presenting Author: Joe Haydamous, MD

Poster #14

Influence of genetic risk awareness on high grade serous fallopian tube carcinoma diagnoses

Presenting Author: Christine Walsh, MD, MS

Poster #15

A Comparative Study of Ovarian Cancer Family History by Germline Genetic Testing Results

Presenting Author: Rebecca Shin, MD

Poster #16

Incorporation of immunotherapy or biological targeted therapy in primary anti-cancer treatment in gynecologic malignancy

Presenting Author: Matthew Lee, MD

Poster #17

The Utility of a Gastrointestinal Workup in Patients Diagnosed with Borderline and Invasive Ovarian Mucinous Neoplasms

Presenting Author: Lauren Tostrud, MD

Poster #18

Real-world outcomes of neoadjuvant chemotherapy for ovarian cancer: What happens to patients who never undergo surgery?

Presenting Author: Kelly Bruce, MD

Poster #19

Mucinous ovarian neoplasm – Outcomes of a rare tumor

Presenting Author: Bahareh Hamedi, MD

Poster #20

Establishing a platform for investigating poly (adenosine diphosphate-ribose) polymerase (PARP) inhibitor sensitivity in PARP1 knockout cells

Presenting Author: Lindsey Nguy, MD

Poster #21

Pathologic staging discrepancies between stage I and II ovarian and tubal high grade serous carcinoma (HGSC) and impact on survival.

Presenting Author: Kayla Sompel, BS

Poster #22

Non-serous fallopian tube carcinoma: a case series

Presenting Author: Joyce Wang, MD

Poster #23

Cancer care navigation, access to care, and adherence to guideline-based cervical cancer treatment across the 2nd largest US public healthcare system

Presenting Author: Alexandra Smick, MD

Poster #24

Implementation of a Cancer Care Navigation Program in Gynecologic Oncology patients within Safety-net Hospitals

Presenting Author: Daisy Cruz, MD

Poster #25

Non-cancer related emergency department utilization in newly diagnosed endometrial cancer patients

Presenting Author: Chrissy Liu, MD

Poster #26

Let’s talk about sex: Sexual wellbeing after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer survivors

Presenting Author: Luis Felipe Falla Zuniga, MD

Poster #27

Palliative care referral and utilization at time of diagnosis in patients with recurrent or advanced stage gynecologic cancers at a single institution

Presenting Author: Breana Hill, MD

Poster #28

Lack of association of routine depression screening results with patient reported needs assessment.

Presenting Author: Alexandra Smick, MD

Poster #29

Outpatient specialty palliative care referral patterns among gynecologic cancer patients

Presenting Author: Rubina Ratnaparkhi, MD

Poster #30

In vitro characterization of patient-derived samples demonstrates the heterogeneity of high grade serous ovarian cancer

Presenting Author: Julia Ritchie, MD

Poster #31

In vitro low passage patient-derived cells demonstrate lack of faithfulness to original sample

Presenting Author: Julia Ritchie, MD

Poster #32

Simplification of Molecular Diagnostics for Point-of-Care HPV Screening

Presenting Author: Jill Roberts, MD

Poster #33

Tumor size predicts overall survival in uterine carcinosarcoma

Presenting Author: Hannah Beer, MD

Poster #34

Characterization and Length of Hospice Admission in Patients with Recurrent Cervical Cancer: A Retrospective Chart Review

Presenting Author: Nicole Spencer, MD

Poster #35

Provider Acceptability of a Biopsy-First Approach to Diagnosis of Endometrial Cancer

Presenting Author: Maya Gross, MD, MPH

Poster #36

Spatial RNA sequencing supports programmed death ligand 2 (PD-L2) as a potential immunotherapy target in high grade serous ovarian carcinoma (HGSOC)

Presenting Author: Elise Yates, MD